Zhongke Biotech (01237) announced that the Group expects to achieve net results for the year ending December 31, 2023...
According to the Zhitong Finance App, Zhongke Biotech (01237) announced that the Group expects the net loss for the year ended December 31, 2023 to be reduced by about 65% compared to the net loss of about RMB 6.8 million for the year ended December 31, 2022. The board believes that the decrease in net loss was mainly due to an increase in bank interest income.